192 related articles for article (PubMed ID: 1680632)
1. The N-acetylation of sulfamethazine and p-aminobenzoic acid by human liver slices in dynamic organ culture.
Gunawardhana L; Barr J; Weir AJ; Brendel K; Sipes IG
Drug Metab Dispos; 1991; 19(3):648-54. PubMed ID: 1680632
[TBL] [Abstract][Full Text] [Related]
2. N-acetylation of the heterocyclic amine batracylin by human liver.
Stevens GJ; Payton M; Sim E; McQueen CA
Drug Metab Dispos; 1999 Sep; 27(9):966-71. PubMed ID: 10460792
[TBL] [Abstract][Full Text] [Related]
3. Kinetic characterization of acetylator genotype-dependent and -independent N-acetyltransferase isozymes in homozygous rapid and slow acetylator inbred hamster liver cytosol.
Trinidad A; Kirlin WG; Ogolla F; Andrews AF; Yerokun T; Ferguson RJ; Brady PK; Hein DW
Drug Metab Dispos; 1989; 17(3):238-47. PubMed ID: 2568903
[TBL] [Abstract][Full Text] [Related]
4. Immunological evidence for N-acetyltransferase isozymes in the rabbit.
Reeves PT; Kinnear BF; Minchin RF; Ilett KF
Mol Pharmacol; 1991 Jan; 39(1):42-8. PubMed ID: 1987451
[TBL] [Abstract][Full Text] [Related]
5. A unique pharmacogenetic expression of the N-acetylation polymorphism in the inbred hamster.
Hein DW; Omichinski JG; Brewer JA; Weber WW
J Pharmacol Exp Ther; 1982 Jan; 220(1):8-15. PubMed ID: 7053425
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of acetyl CoA: arylamine N-acetyltransferase from rapid and slow acetylator human liver.
Kilbane AJ; Petroff T; Weber WW
Drug Metab Dispos; 1991; 19(2):503-7. PubMed ID: 1676662
[TBL] [Abstract][Full Text] [Related]
7. Expression of monomorphic arylamine N-acetyltransferase (NAT1) in human leukocytes.
Cribb AE; Grant DM; Miller MA; Spielberg SP
J Pharmacol Exp Ther; 1991 Dec; 259(3):1241-6. PubMed ID: 1762071
[TBL] [Abstract][Full Text] [Related]
8. Induction of sulfamethazine acetylation by hydrocortisone in the rabbit.
Reeves PT; Minchin RF; Ilett KF
Drug Metab Dispos; 1988; 16(1):110-5. PubMed ID: 2894938
[TBL] [Abstract][Full Text] [Related]
9. Human placental transfer and metabolism of p-aminobenzoic acid.
Derewlany LO; Knie B; Koren G
J Pharmacol Exp Ther; 1994 May; 269(2):761-5. PubMed ID: 8182543
[TBL] [Abstract][Full Text] [Related]
10. Identification and kinetic characterization of acetylator genotype-dependent and -independent arylamine carcinogen N-acetyltransferases in hamster bladder cytosol.
Yerokun T; Kirlin WG; Trinidad A; Ferguson RJ; Ogolla F; Andrews AF; Brady PK; Hein DW
Drug Metab Dispos; 1989; 17(3):231-7. PubMed ID: 2568902
[TBL] [Abstract][Full Text] [Related]
11. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes.
Grant DM; Blum M; Beer M; Meyer UA
Mol Pharmacol; 1991 Feb; 39(2):184-91. PubMed ID: 1996083
[TBL] [Abstract][Full Text] [Related]
12. N-acetylation pharmacogenetics. Michaelis-Menten constants for arylamine drugs as predictors of their N-acetylation rates in vivo.
Andres HH; Weber WW
Drug Metab Dispos; 1986; 14(4):382-5. PubMed ID: 2873982
[TBL] [Abstract][Full Text] [Related]
13. Liver slices: an in vitro system for determination of N-acetylation in human liver.
Gunawardhana L; Barr J; Weir AJ; Brendel K; Sipes IG
Proc West Pharmacol Soc; 1988; 31():137-41. PubMed ID: 3264914
[No Abstract] [Full Text] [Related]
14. Acetylation pharmacogenetics. The slow acetylator phenotype is caused by decreased or absent arylamine N-acetyltransferase in human liver.
Grant DM; Mörike K; Eichelbaum M; Meyer UA
J Clin Invest; 1990 Mar; 85(3):968-72. PubMed ID: 2312737
[TBL] [Abstract][Full Text] [Related]
15. Polymorphic expression of acetyl coenzyme A-dependent arylamine N-acetyltransferase and acetyl coenzyme A-dependent O-acetyltransferase-mediated activation of N-hydroxyarylamines by human bladder cytosol.
Kirlin WG; Trinidad A; Yerokun T; Ogolla F; Ferguson RJ; Andrews AF; Brady PK; Hein DW
Cancer Res; 1989 May; 49(9):2448-54. PubMed ID: 2784998
[TBL] [Abstract][Full Text] [Related]
16. Characterization of arylamine acetyltransferase in the rabbit eye.
Campbell DA; Schoenwald RD; Duffel MW; Barfknecht CF
Invest Ophthalmol Vis Sci; 1991 Jul; 32(8):2190-200. PubMed ID: 2071333
[TBL] [Abstract][Full Text] [Related]
17. Relationship between in vivo acetylator phenotypes and cytosolic N-acetyltransferase and O-acetyltransferase activities in human uroepithelial cells.
Frederickson SM; Messing EM; Reznikoff CA; Swaminathan S
Cancer Epidemiol Biomarkers Prev; 1994; 3(1):25-32. PubMed ID: 8118381
[TBL] [Abstract][Full Text] [Related]
18. Arylamine N-acetyltransferase activity of the human placenta.
Derewlany LO; Knie B; Koren G
J Pharmacol Exp Ther; 1994 May; 269(2):756-60. PubMed ID: 8182542
[TBL] [Abstract][Full Text] [Related]
19. Inheritance of acetylator phenotype in mice.
Tannen RH; Weber WW
J Pharmacol Exp Ther; 1980 Jun; 213(3):480-4. PubMed ID: 6970808
[TBL] [Abstract][Full Text] [Related]
20. Distribution of 2-aminofluorene and p-aminobenzoic acid N-acetyltransferase activity in tissues of C57BL/6J rapid and B6.A-NatS slow acetylator congenic mice.
Chung JG; Levy GN; Weber WW
Drug Metab Dispos; 1993; 21(6):1057-63. PubMed ID: 7905384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
